Bill > HB1538

This bill establishes the Maternal Health Monitoring Pilot Program within the Maryland Department of Health to support pregnant and postpartum Medical Assistance Program recipients with maternal hypertension or maternal diabetes. The program will run during fiscal years 2026 and 2027, with a participating managed care organization (MCO) selected to administer the initiative. Eligible participants must be pregnant, enrolled in the participating MCO, and diagnosed with maternal hypertension or diabetes. The MCO will contract with a technology vendor to provide remote patient monitoring services, using FDA-authorized technology that electronically collects and transmits health data such as blood pressure, weight, and blood glucose levels. The technology vendor will provide preprogrammed devices to participants, deliver them during the second and third trimesters and up to three months postpartum, and train participants on device usage. A specialized nursing team will monitor participant health data, establish protocols for immediate medical attention if needed, and provide health coaching on condition management and nutrition. The Department of Health will ensure geographic diversity in program participation and will receive a report on the pilot program's findings by October 1, 2027. The state will allocate $600,000 for the program, with $2,000 paid per participant to the MCO, and the bill will automatically expire on June 30, 2028.

Government Affairs, Health and Social Services

https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1538?ys=2025RS